Author:
Booth Christopher M.,Robert Siemens David,Peng Yingwei,Mackillop William J.
Reference30 articles.
1. Winquist E, Waldron T, Segal R, Chin J, Likka H. Use of neoadjuvant chemotherapy in transitional cell carcinoma of the bladder Practice Guideline Report #3-2-2. Cancer Care Ontario Program in Evidence-Based Care, editor. https://www.cancercare.on.ca/toolbox/qualityguidelines/diseasesite/genito-ebs/; 2005 [Ref Type: Report, accessed on 9.05.2013].
2. Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer;Sternberg;Urology,2007
3. Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up;Bellmunt;Ann Oncol,2009
4. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma—a practice guideline;Segal;Can J Urol,2002
5. Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer;Porter;Urol Oncol,2011
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献